Skip to main content

PTEN Hamartoma Tumor Syndrome

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 16 Accesses

Synonyms

A number of names including Bannayan-Riley-Ruvalcaba syndrome, Bannayan-Ruvalcaba-Riley syndrome, Bannayan-Zonana syndrome, and Myhre-Riley-Smith syndrome

Definition

The PTEN hamartoma tumor syndrome is an inherited autosomal dominant condition characterized by a spectrum of four major disorders, each with germline mutations in the PTEN (phosphatase and tensin homolog) tumor suppressor gene. The spectrum includes Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome. Based on similar clinical and genotypic features, some researchers have proposed that these syndromes including Cowden syndrome represent a spectrum of a single disorder instead of four distinct entities. Since Cowden syndrome has comprehensively been described in a separate chapter, herein we will discuss the non-Cowden syndrome PTEN hamartoma tumor syndromes.

Clinical Features

  • Bannayan-Riley-Ruvalcaba syndromeis a rare congenital disorder characterized by...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

  • Eng, C. (2001, November 29). PTEN hamartoma tumor syndrome. [Updated 2016 Jun 2]. In: M. P. Adam , H. H. Ardinger, R. A. Pagon, et al., (Eds.). GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2019. https://www.ncbi.nlm.nih.gov/books/NBK1488/

  • Hobert, J., & Eng, C. (2009). PTEN hamartoma tumor syndrome: An overview. Genetics in Medicine, 11, 687–694.

    Article  CAS  PubMed  Google Scholar 

  • Lindhurst, M. J., Sapp, J. C., Teer, J. K., Johnston, J. J., Finn, E. M., Peters, K., et al. (2011). A mosaic activating mutation in AKT1 associated with the Proteus syndrome. The New England Journal of Medicine, 365(7), 611–619.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marsh, D. J., Coulon, V., Lunetta, K. L., Rocca-Serra, P., Dahia, P. L., Zheng, Z., et al. (1998). Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Molecular Genetics, 7, 507–515.

    Article  CAS  PubMed  Google Scholar 

  • Mester, J. L., Tilot, A. K., Rybicki, L. A., Frazier, T. W., 2nd, & Eng, C. (2011). Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in PTEN knock-in murine model. European Journal of Human Genetics: EJHG, 19(7), 763–768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ngeow, J., Mester, J., Rybicki, L. A., Ni, Y., Milas, M., & Eng, C. (2011). Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. The Journal of Clinical Endocrinology and Metabolism, 96(12), E2063–E2071.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ni, Y., Zbuk, K. M., Sadler, T., Patocs, A., Lobo, G., Edelman, E., et al. (2008). Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. American Journal of Human Genetics, 83, 261–268.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pilarski, R., Burt, R., Kohlman, W., Pho, L., Shannon, K. M., & Swisher, E. (2013). Cowden syndrome and the PTEN hamartoma tumor syndrome: Systematic review and revised diagnostic criteria. Journal of the National Cancer Institute, 105(21), 1607–1616.

    Article  CAS  PubMed  Google Scholar 

  • Plamper, M., Schreiner, F., Gohlke, B., Kionke, J., Korsch, E., Kirkpatric, K. J., et al. (2018). Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS). European Journal of Pediatrics, 177(3), 429–435.

    Article  PubMed  Google Scholar 

  • Smith, J. M., Kirk, E. P., Theodosopoulos, G., Marshall, G. M., Walker, J., Rogers, M., Field, M., Brereton, J. J., & Marsh, D. J. (2002). Germline mutation of the tumour suppressor PTEN in Proteus syndrome. Journal of Medical Genetics, 39(12), 937–940.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yehia, L., Ni, Y., & Eng, C. (2017). Germline TTN variants are enriched in PTEN-wildtype Bannayan-Riley-Ruvalcaba syndrome. NPJ Genomic Medicine, 2, 37.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yehia, L., Ni, Y., Sesock, K., Niazi, F., Fletcher, B., Chen, H. J. L., LaFramboise, T., & Eng, C. (2018). Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations. PLoS Genetics, 14(4), e1007352.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ozgur Mete .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Pakbaz, S., Hodgson, A., Mete, O. (2020). PTEN Hamartoma Tumor Syndrome. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5227-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_5227-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics